How Hinge Bio Runs Phase I Trials With Medrio EDC, ePRO and RTSM

Launching a first-in-human Phase I study, Hinge Bio needed a clinical trial technology partner that could match its pace, without the cost, complexity, and long timelines of enterprise vendors.

To ensure efficiency and reduce site burden, Hinge Bio chose Medrio EDC, ePRO, and RTSM.

In this downloadable case study, see how Hinge Bio uses Medrio to achieve:

Accelerated study timelines
Predictable costs and flexible terms
Streamlined site and team experience

Contributing experts at Hinge Bio include:
Kristen Quigley, Chief Clinical Operations Officer
Sarah Huntley, Clinical Data Management
Joshua Pellam, Clinical Lead

Complete this form to download this Case Study.

"*" indicates required fields

URL

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Email Address*

Company Name*

Marketing Email Subscription Preferences

I authorize Medrio to contact me with relevant content, products, and services. You may unsubscribe at any time.

Legal basis for processing contact's data*

I have read Medrio's privacy policy, and consent to my data being stored and processed. *